Insider Transactions Reported by 11 Insiders of ATOSSA THERAPEUTICS, INC.

Symbol
ATOS on Nasdaq
Location
Seattle, WA

Insiders trading volume in the past year

ATOSSA THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
STEVEN C. QUAY President & CEO, Director $30K +$9.89K +49.1% 21 May 2025
H. Lawrence Remmel Director $7.18K +$7K +3889% 15 May 2025
GREGORY WEAVER Former EVP, CFO, & Director, Director $36.00 15 Nov 2023
Richard Steinhart Director 15 May 2025
Stephen J. Galli Director 15 May 2025
Heather Rees Chief Financial Officer 15 May 2025
Shu-Chih Chen Director 15 May 2025
Tessa Cigler Director 15 May 2025
Kyle Guse CFO, Gen Counsel and Secretary 02 Mar 2023
Jonathan Finn Director 15 May 2025
Mark James Daniel Chief Financial Officer 14 Oct 2025

Recent Insider Transactions by Companies or Individuals for ATOSSA THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.